Skip to the main content.
Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Live Webinar + Q&A

From Concept to Market: Why Clinical Evaluation must Start at the First Sketch

Tuesday, February 17, 2026

11:00 a.m. Central European Time

Register Now

 

Webinar Summary

Why Clinical Evaluation must Start at the First Sketch 

Clinical evaluation is often handled at the end of technical documentation development. That approach looks efficient, until the Notified Body questions your endpoints, comparators, benefit-risk logic, or clinical evidence plan and your timeline slips.

In this webinar, we will show how to start clinical evaluation early so it actively guides development decisions. You will learn how an early state-of-the-art assessment helps define what “good enough” looks like clinically, how to avoid the “template trap,” and how to structure clinical evaluation as a living process across the device lifecycle. We will also clarify a common misunderstanding: state-of-the-art supports technology and competitor understanding, but it does not automatically tell you your market access path.

Walk away with a practical approach to planning clinical evaluation to support MDR expectations for sufficient clinical evidence.

What you will Learn

  • How to use clinical evaluation early to set claims, outcomes, and performance thresholds before design is locked

  • What MDR expects from clinical evaluation planning and ongoing updates (not just a one-time report)

  • How to structure an MDR-ready state-of-the-art section, and what it can and cannot tell you

Who Should Attend

RA/QA leaders building or scaling a QMS. Founders, CTOs, and product leads building devices for EU markets. Clinical, medical, and scientific teams responsible for CER, PMCF, and technical documentation.

Screenshot 2026-01-28 at 3.53.38 PM

Núria Gresa

Scientific Affairs Manager

Speaker

Screenshot 2026-01-28 at 3.52.28 PM

Sergi Masgrau

Senior Scientific Affairs Associate

Moderator

Build smarter programs with an Innovation CRO

When teams are siloed, rework is predictable. Explore the iCRO approach that aligns strategy, evidence generation, and execution across the full device lifecycle.